Carlos Doti, MD

Carlos Doti, MD

Articles by Carlos Doti, MD

Dr. Carlos Doti Explains How AstraZeneca's Lynparza Has Impacted Oncology

Carlos Doti, MDBreast Cancer News | March 26, 2025

Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.